| Total Revenue | | 0 | 0 | 0 | |
| Cost of Goods Sold Incl. D&A | | 0 | 0 | 0 |
| Gross Profit | | 0 | 0 | 0 |
| Selling, General and Administrative Excl. Other | | 21 | 18 | 19 |
| Research and Development | | 158 | 125 | 86 |
| Other Operating Expense | | 0 | -1 | 0 |
| Operating Income | | -179 | -142 | -105 |
| Interest Expense | | 0 | 0 | — |
| Unusual Expense | | — | — | — |
| Non-Operating Income (Expense) | | -16 | -13 | -8 |
| Net Income Before Taxes | | -162 | -129 | -97 |
| Income Taxes | | 0 | 0 | 0 |
| Consolidated Net Income | | -162 | -129 | -97 |
| Net Income From Continuing Operations | | -162 | -129 | -97 |
| Net Income | | -162 | -129 | -97 |
| EPS (Recurring) | | -1.87 | -2.20 | -2.14 |
| EPS (Basic, Before Extraordinaries) | | -1.87 | -2.20 | -2.14 |
| EPS (Diluted) | | -1.87 | -2.20 | -2.14 |
| EBITDA | | -162 | -129 | -96 |
| Other After Tax Adjustments | | — | — | — |
| Stock Option Compensation Expense | | — | — | — |
| Price To Earnings Ratio | | — | — | — |
| Price To Sales Ratio | | — | — | — |
| Gross Margin | | — | — | — |
| Operating Margin | | — | — | — |
| Net Margin | | — | — | — |
| Shares Outstanding | | 87 | 59 | 45 |
| Market Capitalization | | 2,175 | — | — |
| Operating Lease Expense | | — | — | — |
